Livasil - Silymarin [Milk thistle] | VetSafeCare.Com

Cap.

Livasil

Silymarin [Milk thistle] — Incepta Pharmaceuticals Ltd.
140mg / capsule · 70mg / capsule

Alternatives

12

Routes

PO

Presentations

2

Generic profile Browse alternatives View combinations

Presentations

Capsule · 140mg / capsule

1 capsule

৳11

Capsule · 70mg / capsule

1 capsule

৳7

Dose rules

No structured dose rules are linked to this brand yet.

Dose reference

Human

1 capsule 2 to 3 times daily or as directed by a physician.

Clinical notes

Applications:

N/A

Indication Notes:
Silymarin (Milk thistle) is indicated for the treatment and prevention of- Liver disease, (non-alcoholic & alcoholic) Liver cirrhosis, (non-alcoholic & alcoholic) Infectious hepatitis Drug-induced hepatitis Liver disease secondary to diabetes mellitus Toxicity of narcotics Fatty liver Jaundice
Avoid In:

N/A

Contraindication Notes:
Contraindicated in patient with a known hypersensitivity to silymarin.
Silymarin, a flavonoid complex of Silybum marianum or Milk thistle, is the biologically active component. It provides hepatocellular protection through toxin blockade at the membrane level, enhances protein synthesis, antioxidant activity, anti-fibrotic activity and possible anti-inflammatory or immunomodulating effects.
Concomitant use of silymarin and butyrophenones or phenothiazines has resulted in the reduction of lipid peroxidation.
Well tolerated in the recommended dose. Occasionally a mild laxative effect may observe.
No experience is available about the use of Silymarin 70 mg or 140 mg during pregnancy and lactation. Therefore, if needed Silymarin 70 mg or 140 mg should be taken with caution according to the physician’s advice.